Cargando…

Medication Overuse and Headache Burden: Results From the CaMEO Study

OBJECTIVE: To estimate the relative frequency of acute medication overuse (AMO) among people with episodic migraine and chronic migraine, to characterize the types of acute medications overused for migraine, and to identify factors associated with AMO. METHODS: We analyzed data from the Chronic Migr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwedt, Todd J., Buse, Dawn C., Argoff, Charles E., Reed, Michael L., Fanning, Kristina M., Hussar, Cory R., Adams, Aubrey Manack, Lipton, Richard B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382341/ https://www.ncbi.nlm.nih.gov/pubmed/34476122 http://dx.doi.org/10.1212/CPJ.0000000000001037

Ejemplares similares

Characterizing opioid use in a US population with migraine: Results from the CaMEO study
por: Lipton, Richard B., et al.
Publicado: (2020)

Pre- and post-headache phases of migraine: multi-country results from the CaMEO – International Study
por: Lipton, Richard B., et al.
Publicado: (2023)

A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache‐Related Disability
por: Lipton, Richard B., et al.
Publicado: (2016)

Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study
por: Lipton, Richard B., et al.
Publicado: (2019)

The Effect of Psychiatric Comorbidities on Headache‐Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Lipton, Richard B., et al.
Publicado: (2020)

The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results
por: Adams, Aubrey Manack, et al.
Publicado: (2015)

Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Lipton, Richard B., et al.
Publicado: (2019)

Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Buse, Dawn C., et al.
Publicado: (2019)

Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Dodick, David W., et al.
Publicado: (2016)

Optimized Acute Treatment of Migraine Is Associated With Greater Productivity in People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Buse, Dawn C., et al.
Publicado: (2023)

Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study
por: Schwedt, Todd J., et al.
Publicado: (2018)

Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) Scale
por: Lipton, Richard B., et al.
Publicado: (2017)

Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study
por: Buse, Dawn C., et al.
Publicado: (2020)

EHMTI-0169. Trajectories of headache days over one year (5 waves) in chronic and episodic migraineurs participating in the chronic migraine epidemiology and outcomes (cameo) study
por: Lipton, RB, et al.
Publicado: (2014)

EHMTI-0099. Migraineur perception regarding family burden from chronic migraine: results of the CAMEO (chronic migraine epidemiology & outcomes) study
por: Buse, DC, et al.
Publicado: (2014)

Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study
por: Munjal, Sagar, et al.
Publicado: (2019)

Consistency vs. switching triptan treatment and headache-related disability: Results of the American migraine prevalence & prevention study
por: Buse, DC, et al.
Publicado: (2013)

Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study
por: Lipton, Richard B., et al.
Publicado: (2019)

Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache
por: Rau, Jill C, et al.
Publicado: (2020)

COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache
por: Martelletti, Paolo
Publicado: (2023)

Defining the Differences Between Episodic Migraine and Chronic Migraine
por: Katsarava, Zaza, et al.
Publicado: (2011)

Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design
por: Serrano, Daniel, et al.
Publicado: (2017)

SysML in action with Cameo Systems Modeler
por: Casse, Olivier
Publicado: (2017)

SysML in action with Cameo Systems Modeler /
por: Casse, Olivier
Publicado: (2017)

Medication-overuse headache: an update
por: Sarchielli, Paola
Publicado: (2015)

Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Depression and risk of transformation of episodic to chronic migraine
por: Ashina, Sait, et al.
Publicado: (2012)

FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
por: Rothrock, John F., et al.
Publicado: (2019)

The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine
por: Silberstein, Stephen D., et al.
Publicado: (2020)

Medication–overuse headache: pathophysiological insights
por: Calabresi, P., et al.
Publicado: (2005)

Medication-overuse headache: a review
por: Kristoffersen, Espen Saxhaug, et al.
Publicado: (2014)

Preventing and treating medication overuse headache
por: Alstadhaug, Karl B., et al.
Publicado: (2017)

Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study
por: Young, William B., et al.
Publicado: (2019)

Comorbid pain and migraine chronicity: The Chronic Migraine Epidemiology and Outcomes Study
por: Scher, Ann I., et al.
Publicado: (2017)

Efficacy and tolerability of oral gastrodin for medication overuse headache (EASTERN): Study protocol for a multicenter randomized double-blind placebo-controlled trial
por: Kong, Fanyi, et al.
Publicado: (2023)

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
por: Diener, Hans-Christoph, et al.
Publicado: (2022)

Treatment and outcome in medication overuse headache patients
por: Mitsikostas, D, et al.
Publicado: (2013)

EHMTI-0303. Treatment of medication overuse headache
por: Madsen, SK, et al.
Publicado: (2014)

Cortical and Subcortical Alterations in Medication Overuse Headache
por: Mehnert, Jan, et al.
Publicado: (2018)

Severity of Analgesic Dependence and Medication-overuse Headache
por: Lundqvist, Christofer, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gfgk9k024scs97jcdka51mdp7j